Titel

Merkliste
1 Ergebnisse

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase ..:

Vano, Yann-Alexandre ; Elaidi, Réza ; Bennamoun, Mostefa...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(22)00128-0. , 2022

Link: https://hal.science/hal-04072026

RT Journal
T1 <Title>Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftutoulouse3hal:oai:HAL:hal-04072026v1&Exemplar=1&LAN=DE
				
A1 Vano, Yann-Alexandre
A1 Elaidi, Réza
A1 Bennamoun, Mostefa
A1 Chevreau, Christine
A1 Borchiellini, Delphine
A1 Pannier, Diane
A1 Maillet, Denis
A1 Gross-Goupil, Marine
A1 Tournigand, Christophe
A1 Laguerre, Brigitte
A1 Barthélémy, Philippe
A1 Coquan, Elodie
A1 Gravis, Gwenaelle
A1 Houédé, Nadine
A1 Cancel, Mathilde
A1 Huillard, Olivier
A1 Beuzeboc, Philippe
A1 Fournier, Laure
A1 Méjean, Arnaud
A1 Cathelineau, Xavier
A1 Doumerc, Nicolas
A1 Paparel, Philippe
A1 Bernhard, Jean-Christophe
A1 de la Taille, Alexandre
A1 Bensalah, Karim
A1 Tricard, Thibault
A1 Waeckel, Thibaut
A1 Pignot, Géraldine
A1 Braychenko, Elena
A1 Caruso, Stefano
A1 Sun, Cheng-Ming
A1 Verkarre, Virginie
A1 Lacroix, Guillaume
A1 Moreira, Marco
A1 Meylan, Maxime
A1 Bougouïn, Antoine
A1 Phan, Letuan
A1 Thibault-Carpentier, Christelle
A1 Zucman-Rossi, Jessica
A1 Fridman, Wolf Herman
A1 Sautès-Fridman, Catherine
A1 Oudard, Stéphane
PB HAL CCSD; Elsevier
YR 2022
K1 MESH: Antineoplastic Combined Chemotherapy Protocols / adverse effects
K1 MESH: Angiogenesis Inhibitors / adverse effects
K1 MESH: Humans
K1 MESH: Ipilimumab
K1 MESH: Lipase
K1 MESH: Male
K1 MESH: Neoplasm Staging
K1 MESH: Nivolumab / adverse effects
K1 MESH: Prospective Studies
K1 MESH: Protein Kinase Inhibitors / adverse effects
K1 MESH: Sunitinib
K1 MESH: Tumor Microenvironment
K1 MESH: Biomarkers
K1 MESH: Carcinoma
K1 Renal Cell / drug therapy
K1 MESH: Female
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
K1 [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
K1 [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/S1470-2045(22)00128-0
LK http://dx.doi.org/https://hal.science/hal-04072026
DO https://hal.science/hal-04072026
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)